Sunshine Biopharma (SBFM) EBIAT: 2010-2025
Historic EBIAT for Sunshine Biopharma (SBFM) over the last 14 years, with Sep 2025 value amounting to -$883,820.
- Sunshine Biopharma's EBIAT rose 26.21% to -$883,820 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.0 million, marking a year-over-year decrease of 41.81%. This contributed to the annual value of -$5.1 million for FY2024, which is 13.94% down from last year.
- Per Sunshine Biopharma's latest filing, its EBIAT stood at -$883,820 for Q3 2025, which was up 50.09% from -$1.8 million recorded in Q2 2025.
- In the past 5 years, Sunshine Biopharma's EBIAT ranged from a high of $667,116 in Q4 2021 and a low of -$23.5 million during Q4 2022.
- In the last 3 years, Sunshine Biopharma's EBIAT had a median value of -$1.2 million in 2024 and averaged -$1.2 million.
- Over the last 5 years, Sunshine Biopharma's EBIAT had its largest YoY gain of 161.55% in 2021, and its largest YoY loss of 6,461.84% in 2021.
- Over the past 5 years, Sunshine Biopharma's EBIAT (Quarterly) stood at $667,116 in 2021, then crashed by 3,624.47% to -$23.5 million in 2022, then surged by 94.68% to -$1.3 million in 2023, then plummeted by 72.65% to -$2.2 million in 2024, then grew by 26.21% to -$883,820 in 2025.
- Its EBIAT stands at -$883,820 for Q3 2025, versus -$1.8 million for Q2 2025 and -$1.2 million for Q1 2025.